Canigen DHA2PPi/LR liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań dla psów
Canigen DHA2PPi/LR liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań dla psów
Ovlašten
- Canine parvovirus, strain Cornell 780916, Live
- Canine adenovirus 2, strain Manhattan, Live
- Canine distemper virus, strain Lederle VR128, Live
- Canine parainfluenza virus, strain Manhattan, Live
- Rabies virus, strain VP12, Inactivated
Identifikacija proizvoda
Naziv VMP-a:
Canigen DHA2PPi/LR liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań dla psów
Način primjene:
-
Supkutano
Pojedinosti o proizvodu
Djelatna tvar i jačina:
-
Dostupno samo u English10000000.00tissue culture infective dose 501.00tissue culture infective dose 50
-
Dostupno samo u English1000000.00tissue culture infective dose 501.00tissue culture infective dose 50
-
Dostupno samo u English100000.00tissue culture infective dose 501.00tissue culture infective dose 50
-
Dostupno samo u English10000000.00tissue culture infective dose 501.00tissue culture infective dose 50
-
Dostupno samo u English1.00internacionalna jedinica1.00internacionalna jedinica
Farmaceutski oblik:
-
Liofilizat i otapalo za suspenziju za injekciju
Withdrawal period by route of administration:
-
Supkutano
- Dog
-
No data provided
-
Kod anatomsko-terapijsko-kemijske klasifikacije (ATKvet kȏd):
- QI07A
Status odobrenja:
-
Važeće
Dodatne informacije
Entitlement type:
-
Marketing Authorisation
Nositelj odobrenja za stavljanje u promet:
- Virbac
Marketing authorisation date:
Mjesta proizvodnje za izdavanje serije:
- VIRBAC
Odgovorno tijelo:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Broj autorizacije:
- 1484
Datum promjene statusa odobrenja:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Koliko je bila korisna ova stranica?: